Oncology Pharma De-Risk Through Collaborations and Novel Combination Therapy Targets
| Pharma Exec

Small biopharmaceutical enterprises face many hurdles and risks with bringing novel therapies to market. Some biopharmaceutical enterprises have de-risked their approaches towards drug development by forging fruitful collaborations with medical research institutions to explore novel combination therapy mechanisms. Spiro Rombotis, president and CEO of Cyclacel, highlights why targeting cyclin-dependent kinases and the DNA repair pathway […]

Survivor doing what he can to help fight childhood cancer
| Click 2 Houston

Neuroblastoma accounts for 6 percent of all cancers in children, and is deadly in kids under 5. Many times, the cancer spreads to the lymph nodes before parents even notice a lump. Now, a 4-year-old boy who fought the disease is helping other kids fight back.

New chondrocyte patents for SpinalCyte
| Spinal News International

SpinalCyte recently announced the issuance of new patents in the USA and Japan. The company’s patent portfolio now includes 39 US and international patents issued with over 100 patents pending focused on the clinical use of fibroblasts. The company received investigational new drug clearance from the US Food and Drug Administration in November 2018 to […]